Emerging Targeted Therapies for Plaque Psoriasis &Ndash; Impact of Ixekizumab

Clinical, Cosmetic and Investigational Dermatology - New Zealand
doi 10.2147/ccid.s111007
Full Text
Abstract

Available in full text

Categories
Dermatology
Date
Authors
Publisher

Informa UK Limited

Related search

Ixekizumab: Targeting Plaque Psoriasis and Psoriatic Arthritis

Prescriber
Pharmacology
2019English

Emerging Combination Therapies for Metastatic Colorectal Cancer &Ndash; Impact of Trifluridine/Tipiracil

Cancer Management and Research
Oncology
2017English

Ovarian Cancer: Emerging Molecular-Targeted Therapies

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2012English

Real-World Drug Survival of Ixekizumab for Psoriasis

Journal of the American Academy of Dermatology
Dermatology
2019English

LB950 the Potential Impact on Future Fertility for Biologics and Emerging Therapies for Psoriasis and Atopic Dermatitis

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2017English

Spotlight on Ixekizumab for the Treatment of Moderate-To-Severe Plaque Psoriasis: Design, Development, and Use in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2017English

Toxoplasmosis in a Patient Receiving Ixekizumab for Psoriasis

JAAD Case Reports
Dermatology
2020English

540 Rapid Response in PASI, sPGA, and BSA Measures for Patients With Moderate-To-Severe Plaque Psoriasis With Ixekizumab

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

New Therapies for Psoriasis

Seminars in Cutaneous Medicine and Surgery
DermatologyMedicineSurgery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy